HEALHTY

This early-stage study tests a new drug called BGM1812 in 60 overweight or obese but otherwise healthy adults. The goal is to check the drug's safety, how the body processes it, and whether it leads to weight loss. Participants receive either the drug or a placebo injection under…

This study tests whether a special video-based game can help adults aged 60 and older improve their balance, thinking skills, and self-confidence. Participants will play the game twice a week for six weeks. Researchers will compare their results to a group that does not play the …

This study looks at whether two simple massage methods—Marmet technique and oxytocin massage—can increase breast milk in mothers who had a C-section. About 123 first-time mothers will be randomly assigned to one of these massages or a light touch (placebo). Researchers will measu…

This study looks at whether MDMA (the active ingredient in ecstasy) can reduce pain. Twenty healthy volunteers will receive either MDMA or a placebo while mild pain is created using small electrical pulses under the skin. Researchers will compare how each group feels the pain to …

This early-stage study is testing a new drug called HSK55879 in 46 healthy adults aged 18 to 45. The main goal is to see if the drug is safe and how the body processes it, including whether food changes its effects. Participants will be randomly assigned to receive the drug or a …

This early-phase trial tests the safety and how the body processes IY-828026 in 86 healthy adults aged 19 to 50. Participants receive single or multiple doses of the drug or a placebo. The study measures side effects, drug levels in blood, and stomach acid changes. It does not ai…

This study looks at how two short-chain fatty acids—propionate and butyrate—affect the body's metabolism in healthy adults. Ten volunteers will take each fatty acid on separate visits, and researchers will measure changes in ketones, glucose, and other markers. The goal is to und…

This study looks at how two natural gut hormones, GIP and GLP-1, affect how the body takes up sugar and moves blood through organs. Researchers will use a special full-body PET scanner to measure these effects in healthy volunteers and people with type 2 diabetes. The goal is to …

This early-stage study is testing a tablet called WD-1603, which contains two drugs used for Parkinson's disease (levodopa and carbidopa). The goal is to see how changing the time between doses affects how the drug moves through the body. Twelve healthy adults will take the table…